Zobrazeno 1 - 10
of 1 336
pro vyhledávání: '"M. Mendenhall"'
Autor:
Sandra Nuyts, Heleen Bollen, Avrahram Eisbruch, Primoz Strojan, William M. Mendenhall, Sweet Ping Ng, Alfio Ferlito
Publikováno v:
Cancer Medicine, Vol 13, Iss 8, Pp n/a-n/a (2024)
Abstract Background Patients with head and neck cancer (HNC) may experience substantial anatomical changes during the course of radiotherapy treatment. The implementation of adaptive radiotherapy (ART) proves effective in managing the consequent impa
Externí odkaz:
https://doaj.org/article/f34867bd7d2b471e9cc497bd28c250ed
Autor:
Eric D. Brooks, MD, MHS, Fantine Giap, MD, Vincent Cassidy, MD, Matthew S. Ning, MD, MPH, Bradlee Robbert, FACHE, MHA, RT(R)(T), Polly Redding, MBS, CPC, CHONC, Matthew Palmer, MBA, L. Montreal Turner, MBA, MHA, CMD, PMP, William M. Mendenhall, MD, Stuart Klein, MHA, Nancy P. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 10, Iss 2, Pp 65-72 (2023)
Purpose: Obtaining prior authorization (PA) before treatment is becoming increasingly burdensome in oncology, especially in radiation oncology. Here, we describe the impact of a strategic novel operational PA redesign to shorten authorization time an
Externí odkaz:
https://doaj.org/article/014bbd825c814cbb8a3a5d127e2b321f
Autor:
William M. Mendenhall, MD, Jonathan J. Beitler, MD, MBA, Nabil F. Saba, MD, FACP, Ashok R. Shaha, MD, FACS, Sandra Nuyts, MD, PhD, Primož Strojan, MD, Heleen Bollen, MD, Oded Cohen, MD, Robert Smee, MD, Sweet Ping Ng, MD, Avraham Eisbruch, MD, Wai Tong Ng, MD, Jessica M. Kirwan, MA, Alfio Ferlito, MD, DLO, DPath, FRCSEd ad hominem, FRCS (Eng, Glasg, Ir) ad eundem, FDSRCS ad eundem, FACS, FHKCORL, FRCPath, FASCP, IFCAP
Publikováno v:
International Journal of Particle Therapy, Vol 9, Iss 4, Pp 243-252 (2023)
Purpose: To discuss the role of proton beam therapy (PBT) in the treatment of patients with oropharyngeal squamous cell carcinoma (OPSCC). Materials and Methods: A review of the pertinent literature. Results: Proton beam therapy likely results in red
Externí odkaz:
https://doaj.org/article/f38473e8146f48049b2d5d531735ec05
A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion
Autor:
Jyoti Sharma, Ming Du, Eric Wong, Venkateshwar Mutyam, Yao Li, Jianguo Chen, Jamie Wangen, Kari Thrasher, Lianwu Fu, Ning Peng, Liping Tang, Kaimao Liu, Bini Mathew, Robert J. Bostwick, Corinne E. Augelli-Szafran, Hermann Bihler, Feng Liang, Jerome Mahiou, Josef Saltz, Andras Rab, Jeong Hong, Eric J. Sorscher, Eric M. Mendenhall, Candice J. Coppola, Kim M. Keeling, Rachel Green, Martin Mense, Mark J. Suto, Steven M. Rowe, David M. Bedwell
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
Premature termination codons can cause early translation termination and lead to disease. Here the authors perform a screen to identify compounds with readthrough activity and show that these reduce eRF1 levels to suppress premature termination assoc
Externí odkaz:
https://doaj.org/article/1010cb2b07ac42418e6fb9795f6fb27c
Autor:
William M. Mendenhall, MD, Eric D. Brooks, MD, MHS, Stephanie Smith, Christopher G. Morris, MS, Curtis B. Bryant, MD, MPH, Randal H. Henderson, MD, Romaine C. Nichols, Jr., MD, Kathy McIntyre, Stuart L. Klein, MHA, Nancy P. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 36-42 (2021)
Purpose: To determine factors that influence insurance approval for definitive proton therapy (PT) for prostate cancer. Materials and Methods: Between 2014 and 2018, 1592 insured patients with localized prostate cancer were evaluated and recommended
Externí odkaz:
https://doaj.org/article/d56f508053b54ed0882190767981a28b
Autor:
Curtis M. Bryant, MD, MPH, Roi Dagan, MD, MS, Adam L. Holtzman, MD, Rui Fernandes, MD, Anthony Bunnell, MD, William M. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 285-293 (2021)
Purpose: To report our experience with the delivery of passively scattered proton therapy in the management of nonmelanoma skin cancers with clinical perineural invasion. Materials and Methods: We reviewed the medical records of patients who received
Externí odkaz:
https://doaj.org/article/4dfad6c3e5ae4fd5ae84d81c17c76bac
Autor:
Roi Dagan, MD, MS, Haruka Uezono, MD, Curtis Bryant, MD, Adam L. Holtzman, MD, Christopher G. Morris, MS, William M. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 200-212 (2021)
Purpose: To report long-term disease control, survival, and toxicity after proton therapy for sinonasal cancer. Patients and Methods: We reviewed 143 cases of adults with nonmetastatic sinonasal cancers treated with primary (18%; n = 26) or adjuvant
Externí odkaz:
https://doaj.org/article/59928fbefea54bc899689b2377dcc556
Autor:
Adam L. Holtzman, MD, Ronny L. Rotondo, MD, Michael S. Rutenberg, MD, PhD, Daniel J. Indelicato, MD, Alexandra De Leo, MD, Dinesh Rao, MD, Jeet Patel, MD, Christopher G. Morris, MS, William M. Mendenhall, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 179-188 (2021)
Purpose: To evaluate the effectiveness of external-beam proton therapy (PT) on local control and survival in patients with skull-base chordoma. Materials and Methods: We reviewed the medical records of patients with skull-base chordoma treated with d
Externí odkaz:
https://doaj.org/article/cd956fe89c3345049a68cfe17ded6b7f
Autor:
Curtis M. Bryant, MD, MPH, Randal H. Henderson, MD, MBA, R. Charles Nichols, MD, William M. Mendenhall, MD, Bradford S. Hoppe, MD, MPH, Carlos E. Vargas, MD, Thomas B. Daniels, MD, C. Richard Choo, MD, Rahul R. Parikh, MD, Huan Giap, MD, PhD, Jerry D. Slater, MD, Neha Vapiwala, MD, William Barrett, MD, Akash Nanda, MD, PhD, Mark V. Mishra, MD, Seungtaek Choi, MD, Jay J. Liao, MD, Nancy P. Mendenhall, MD, the Genitourinary Subcommittee of the Particle Therapy Co-Operative Group
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 2, Pp 1-16 (2021)
Proton therapy is a promising but controversial treatment in the management of prostate cancer. Despite its dosimetric advantages when compared with photon radiation therapy, its increased cost to patients and insurers has raised questions regarding
Externí odkaz:
https://doaj.org/article/871926a9f47046e99a4987b232eaa487
Autor:
Shivam M. Kharod, MD, Catherine E. Mercado, MD, Christopher G. Morris, MS, Curtis M. Bryant, MD, MPH, Nancy P. Mendenhall, MD, William M. Mendenhall, MD, R. Charles Nichols, MD, Bradford S. Hoppe, MD, MPH, Xiaoying Liang, PhD, Zhong Su, PhD, Zuofeng Li, DSc, Randal H. Henderson, MD, MBA
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 4, Pp 52-64 (2021)
Purpose: Postprostatectomy radiation improves disease control, but limited data exist regarding outcomes, toxicities, and patient-reported quality of life with proton therapy. Method and Materials: The first 102 patients who were enrolled on an outco
Externí odkaz:
https://doaj.org/article/8f335a2fb6b5444383014baf7ca5424e